- $68.27m
- $50.29m
- $58.44m
Annual balance sheet for LENSAR, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31.6 | 14.7 | 24.1 | 22.5 | 18 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.99 | 6.57 | 5.31 | 6.72 | 6.67 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 44.8 | 33.7 | 46.4 | 42 | 46.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.6 | 9.51 | 10.3 | 16.9 | 18.5 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 66.5 | 55.8 | 69.6 | 66.3 | 71.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.71 | 11.4 | 11.6 | 15 | 40.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.6 | 13.9 | 22.4 | 47.7 | 83.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 54.9 | 42 | 47.2 | 18.6 | -12.2 |
| Total Liabilities & Shareholders' Equity | 66.5 | 55.8 | 69.6 | 66.3 | 71.4 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |